Fibroblasts: The Hidden Drivers of Gut Cancer

The link between long‑term gut inflammation and colorectal cancer is clear, but the focus has usually been on DNA changes in the lining cells. Recent research shows that the surrounding support cells, called fibroblasts, play a much bigger part than previously thought. These cells build the structure around tissues and can change their behavior over time, forming a supportive environment for cancer to grow.

Fibroblasts: Active Partners in Disease

Scientists now see fibroblasts as active partners in the disease process. They change together with the lining cells and immune system, creating a “pre‑cancer” niche.
A new idea called stromal inflammatory memory suggests that past inflammation leaves a lasting mark on fibroblasts through stable DNA‑related changes and altered metabolism. One key change is a shift toward glycolysis driven by the enzyme PFKFB3, which keeps the tissue in a state that favours tumor growth even when symptoms seem to disappear.

When Organization Breaks Down

When the normal organization of lining cells breaks down—such as loss of proteins that keep cell polarity—the communication between the lining and fibroblasts intensifies. The body’s constant exposure to gut bacteria and signals from molecules like hyaluronan further drive this interaction. Over time, fibroblasts diversify into several types:

• Inflammatory (iCAF)
• Contractile (myCAF)
• Antigen‑presenting (apCAF)

Together, they help cancer cells hide from the immune system by tiring out T‑cells and physically blocking them.

Metabolic Warfare

The way these fibroblasts influence cancer also involves metabolic changes in nearby cells, known as the Reverse Warburg Effect, and the release of tiny packages called exosomes that can make chemotherapy less effective. Because of this, treatments that only target the lining cells may miss a critical piece of the puzzle.

Re‑Training Fibroblasts

New technologies that examine single cells and their positions in tissue reveal opportunities to re‑train fibroblasts. By adjusting their metabolism, epigenetic marks, or aging signals, doctors might stop the supportive environment from forming and curb cancer development in patients with chronic gut inflammation.